Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells

Vasohibin-1 (VASH1) is a VEGF-inducible gene of endothelial cells (ECs) that acts as a negative feedback regulator of angiogenesis. To further characterize the function of VASH1, we transfected human VASH1 gene into the mouse EC line MS1, established stable VASH1 expressing clones, and determined ge...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasufumi Sato (Author), Hiroki Miyashita (Author), Akihide Ohkuchi (Author), Hirotada Suzuki (Author)
Format: Book
Published: MDPI AG, 2011-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_271ffa3efd6744dc98cd2db07bc3e7e1
042 |a dc 
100 1 0 |a Yasufumi Sato  |e author 
700 1 0 |a Hiroki Miyashita  |e author 
700 1 0 |a Akihide Ohkuchi  |e author 
700 1 0 |a Hirotada Suzuki  |e author 
245 0 0 |a Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells 
260 |b MDPI AG,   |c 2011-05-01T00:00:00Z. 
500 |a 10.3390/ph4060782 
500 |a 1424-8247 
520 |a Vasohibin-1 (VASH1) is a VEGF-inducible gene of endothelial cells (ECs) that acts as a negative feedback regulator of angiogenesis. To further characterize the function of VASH1, we transfected human VASH1 gene into the mouse EC line MS1, established stable VASH1 expressing clones, and determined gene alteration by cDNA microarray analysis. Among the various angiogenesis-related genes, vascular endothelial growth factor type 1 receptor (VEGFR-1) and its alternative spliced form, soluble VEGFR1 (sVEGFR-1), were found to be the most significantly down-regulated genes. Transient overexpression of VASH1 in human umbilical vein endothelial cells confirmed the down-regulation of VEGFR-1 and sVEGFR-1. sVEGFR-1 is a decoy receptor for VEGF and inhibits angiogenesis. Interestingly, when sVEGFR-1 was overexpressed in ECs, it inhibited the expression of VASH1 in turn. These results suggest that VASH1 and sVEGFR-1, two angiogenesis inhibitors, mutually balance their expressions in ECs. 
546 |a EN 
690 |a angiogenesis inhibitor 
690 |a endothelial cell 
690 |a VASH1 
690 |a sVEGFR-1 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 4, Iss 6, Pp 782-793 (2011) 
787 0 |n http://www.mdpi.com/1424-8247/4/6/782/ 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/271ffa3efd6744dc98cd2db07bc3e7e1  |z Connect to this object online.